Leslie Donato, RIS Rx Board Member
I’m incredibly excited to announce that Leslie Donato has been appointed to the RIS Rx Board of Directors.
Leslie’s deep expertise in corporate strategy is vital for RIS Rx’s next stage of growth.
She served as Executive Vice President and Chief Strategy Officer at Cencora where she led transformative M&A activity that fueled a 130% increase in market capitalization. Previously, she held leadership roles at Bayer | Pharmaceuticals and served as a Principal at McKinsey & Company’s Pharmaceutical & Medical Products Practice.
Today, she also serves on the Boards of Keenova, COPILOT Provider Support Services, and Virtua Health, helping architect their strategic future and accelerate commercial performance.
Grateful to have the tremendous benefit of her guidance. Welcome, Leslie!
